REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 61 filers reported holding REDHILL BIOPHARMA LTD in Q3 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $32 | -99.9% | 228,430 | +139.4% | 0.01% | -36.4% |
| Q3 2022 | $48,000 | -42.2% | 95,430 | 0.0% | 0.01% | -38.9% |
| Q2 2022 | $83,000 | -65.4% | 95,430 | 0.0% | 0.02% | -60.9% |
| Q1 2022 | $240,000 | -2.4% | 95,430 | 0.0% | 0.05% | +2.2% |
| Q4 2021 | $246,000 | -14.3% | 95,430 | +52.1% | 0.04% | -8.2% |
| Q3 2021 | $287,000 | -24.1% | 62,730 | +14.1% | 0.05% | -21.0% |
| Q2 2021 | $378,000 | -6.0% | 54,972 | 0.0% | 0.06% | -17.3% |
| Q1 2021 | $402,000 | -9.5% | 54,972 | 0.0% | 0.08% | -14.8% |
| Q4 2020 | $444,000 | -3.5% | 54,972 | +22.2% | 0.09% | -13.7% |
| Q3 2020 | $460,000 | +52.8% | 44,972 | 0.0% | 0.10% | +43.7% |
| Q2 2020 | $301,000 | -5.0% | 44,972 | -35.7% | 0.07% | -20.2% |
| Q1 2020 | $317,000 | -30.5% | 69,972 | -6.8% | 0.09% | +1.1% |
| Q4 2019 | $456,000 | -13.8% | 75,102 | 0.0% | 0.09% | -19.3% |
| Q3 2019 | $529,000 | +32.2% | 75,102 | +22.1% | 0.11% | +31.3% |
| Q2 2019 | $400,000 | -28.7% | 61,502 | -8.9% | 0.08% | -25.9% |
| Q1 2019 | $561,000 | +49.6% | 67,522 | 0.0% | 0.11% | +34.9% |
| Q4 2018 | $375,000 | -10.7% | 67,522 | +42.1% | 0.08% | +2.5% |
| Q3 2018 | $420,000 | +3.7% | 47,522 | 0.0% | 0.08% | -2.4% |
| Q2 2018 | $405,000 | +64.6% | 47,522 | 0.0% | 0.08% | +48.2% |
| Q1 2018 | $246,000 | +12.3% | 47,522 | +11.8% | 0.06% | +16.7% |
| Q4 2017 | $219,000 | – | 42,522 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |